Cambium Bio Limited has released a press release.
Successful Private Placement
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Cambium Bio
- Positive results for Progenza in treating neuropathic pain
- Directors Provide $2.5M Loan to Extend Funding Runway
- Response to ASX Appendix 4C Query Letter
- New CEO Appointed to Accelerate Global Growth
- Chinese patent granted for biomarkers for stem cell therapy
Later from Cambium Bio
- Investor Presentation
- Offer Booklet
- Updated Investor Presentation
- Restructuring results in 50% reduction in operating costs
- Appendix 4E
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio